Pediatric Pulmonology & Respiratory Intermediate Care Unit, Sleep and Long Term Ventilation Unit, Academic Department of Pediatrics (DPUO), Pediatric Hospital "Bambino Gesù" Research Institute, Piazza S. Onofrio 4, 00165, Rome, Italy.
Ital J Pediatr. 2020 Jan 31;46(1):12. doi: 10.1186/s13052-020-0778-8.
Children with chronic respiratory failure and/or sleep disordered breathing due to a broad range of diseases may require long-term ventilation to be managed at home. Advances in the use of long-term non-invasive ventilation has progressively leaded to a reduction of the need for invasive mechanical ventilation through tracheostomy. In this study, we sought to characterize a cohort of children using long-term NIV and IMV and to perform an analysis of those children who showed significant changes in ventilatory support management.
We performed a retrospective cohort study of pediatric (within 18 years old) patients using long-term, NIV and IMV, hospitalized in our center between January 1, 2000 and December 31, 2017. A total of 432 children were included in the study. Long Term Ventilation (LTV) was defined as IMV or NIV, performed on a daily basis, at least 6 h/day, for a period of at least 3 months.
315 (72.9%) received non-invasive ventilation (NIV); 117 (27.1%) received invasive mechanical ventilation (IMV). Children suffered mainly from neuromuscular (30.6%), upper airway (24.8%) and central nervous system diseases (22.7%). Children on IMV were significantly younger when they start LTV [NIV: 6.4 (1.2-12.8) years vs IMV 2.1 (0.8-7.8) years] (p < 0.001)]. IMV was likely associated with younger age at starting ventilatory support (aOR 0.9428; p = 0.0220), and being a child with home health care (aOR 11.4; p < 0.0001). Overtime 39 children improved (9%), 11 children on NIV (3.5%) received tracheostomy; 62 children died (14.3%); and 74 children (17.1%) were lost to follow-up (17.8% on NIV, 15.4% on IMV).
Children on LTV suffered mainly from neuromuscular, upper airways, and central nervous system diseases. Children invasively ventilated usually started support younger and were more severely ills.
患有慢性呼吸衰竭和/或睡眠呼吸障碍的儿童可能由于广泛的疾病而需要长期在家中接受通气治疗。长期无创通气的应用进展使得通过气管切开术进行有创机械通气的需求逐渐减少。在这项研究中,我们旨在描述一组使用长期无创通气和有创机械通气的儿童,并对通气支持管理发生显著变化的患儿进行分析。
我们对 2000 年 1 月 1 日至 2017 年 12 月 31 日期间在我们中心住院的使用长期、无创通气和有创机械通气的儿科(18 岁以下)患者进行了回顾性队列研究。共纳入 432 例患儿。长期通气(LTV)定义为每天至少 6 小时、至少 3 个月进行的有创机械通气或无创通气。
315 例(72.9%)接受无创通气(NIV);117 例(27.1%)接受有创机械通气(IMV)。患儿主要患有神经肌肉(30.6%)、上呼吸道(24.8%)和中枢神经系统疾病(22.7%)。开始 LTV 时,接受 IMV 的患儿明显更小[NIV:6.4(1.2-12.8)岁 vs IMV:2.1(0.8-7.8)岁](p<0.001)]。IMV 与通气支持开始时年龄较小相关(优势比 0.9428;p=0.0220),且与在家中接受健康护理的儿童相关(优势比 11.4;p<0.0001)。随着时间的推移,39 例患儿(9%)好转,11 例接受 NIV 的患儿(3.5%)接受了气管切开术,62 例患儿(14.3%)死亡,74 例患儿(17.1%)失访(NIV 患儿失访率为 17.8%,IMV 患儿失访率为 15.4%)。
接受 LTV 的患儿主要患有神经肌肉、上呼吸道和中枢神经系统疾病。通常接受有创通气的患儿开始治疗时年龄较小,病情更严重。